Pivotal Therapeutics Inc. announced that Mr. Eugenio Bortoluzzi resigned on May 6, 2016 as Director, Chief Executive Officer and Chief Financial Officer of the company. Mrs. Rachelle MacSweeney, President and Chief Operating Officer, has been named Interim Chief Executive Officer.